MONT-SAINT-GUIBERT, Belgium, November 21, 2024--(BUSINESS WIRE)--Cellistic®, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing, announces the successful audit and ...

Cellistic®, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing, announces the successful audit and GMP certification of its first-of-its kind facility dedicated to ...

FUJIFILM Corporation is investing $188 million in a cell culture media manufacturing facility in Research Triangle Park ... which leaves plenty of room for growth. The site will support current Good ...

MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Cellistic®, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing, announces the successful audit and GMP certification of its ...

Abzena, a CDMO, said it has expanded its early- and late-phase analytical capabilities to now include GMP cell-based potency assays at their Cambridge, U.K., and San Diego, CA, development and ...

GMP cell-based potency assays play an essential role in quantitatively measuring the biological activity of a biopharmaceutical, and the cytotoxicity of the payload of an Antibody-drug conjugate ...

“As a product manager for cell culture applications, I was concerned to establish a bioprinting portfolio ... While also focussing on clinical translation for example by including GMP-like inks in ...

We proposed that oxidative reddening might represent a considerable (or even primary) component of photobleaching of fluorescent proteins during live-cell imaging and that this undesirable ...

CAMBRIDGE, England and SAN DIEGO, Nov. 19, 2024 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, announced the expansion of their early ...